Pre-Close Trading Update

RNS Number : 2167V

Alliance Pharma PLC

07 July 2009

 



For Immediate Release

7 July 2009

ALLIANCE PHARMA PLC

('Alliance' or 'the Company')

Pre-close Trading Update

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces a pre-close trading update ahead of the announcement of its interim results for the six months ended 30 June 2009.

Trading has been strong with half year sales in the region of £13.2m, an increase of 33% over the first half of last year.

There has also been an improvement in average gross margin rates as a result of changes in the sales mix. Consequently, profit before tax for the half year is now expected to be not less than £2.7m.

The Board reaffirms its intention to commence dividend payments by early 2010.

The Company's interim results are due to be announced on 9 September 2009.

For further information: 

Alliance Pharma plc		+ 44 (0) 1249 466966
	John Dawson, Chief Executive
	Richard Wright, Finance Director
	www.alliancepharma.co.uk
	Buchanan Communications	+ 44 (0) 20 7466 5000
	Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
	Numis Securities Limited	+ 44 (0) 20 7260 1000
	Nominated Adviser: Michael Meade / Brent Nabbs
	Corporate Broking: David Poutney

 

  

Notes to editors

About Alliance Pharma

Alliance Pharma, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham,  Wiltshire, UK. The company has a strong track record of acquiring the rights to established niche brands and owns, or licenses, the rights to 35 branded pharmaceutical products and continues to explore opportunities to expand the range.

Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in the treatment of dermatological conditions, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies with their prescription requirements.

Alliance Pharma joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

 

END

 

 

MSCSSIFMMSUSEEW